Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoid”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04794296
What this trial is testing

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

Who this might be right for
Childhood ALL
French Africa Pediatric Oncology Group 500
Early research (Phase 1)Study completedNCT00002946
What this trial is testing

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Post-approval studies (Phase 4)UnknownNCT00192673
What this trial is testing

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

Who this might be right for
Acute Lymphoblastic Leukemia
Nordic Society for Pediatric Hematology and Oncology 85
Testing effectiveness (Phase 2)Ended earlyNCT00281931
What this trial is testing

Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia

Who this might be right for
Prolymphocytic Leukemia
German CLL Study Group 21
Early research (Phase 1)Not Yet RecruitingNCT07692529
What this trial is testing

A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocyte LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Testing effectiveness (Phase 2)Study completedNCT02254772
What this trial is testing

A Phase I/II Study of Intratumoral Injection of SD-101

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
Robert Lowsky 9
Early research (Phase 1)Study completedNCT00867230
What this trial is testing

FTS Study in Patients With Advanced Hematologic Malignancies

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT03147365
What this trial is testing

Effect of Different Exercises on Quality of Life of Leukemia Patients.

Who this might be right for
Quality of LifeAcute Lymphoblastic LeukemiaExercise
Children's Cancer Hospital Egypt 57357 75
Not applicableStudy completedNCT03385681
What this trial is testing

Pediatric Pain Management - an Intervention Study

Who this might be right for
Postoperative PainPediatric ALL
Oslo University Hospital 876
Testing effectiveness (Phase 2)Looking for participantsNCT05417165
What this trial is testing

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Seema Bhat 80
Testing effectiveness (Phase 2)Study completedNCT00345345
What this trial is testing

Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

Who this might be right for
T-LGL Lymphoproliferative Disorders
National Heart, Lung, and Blood Institute (NHLBI) 29
Not applicableUnknownNCT02888977
What this trial is testing

Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL

Who this might be right for
Lymphoblastic Leukemia, Acute
Versailles Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT00810680
What this trial is testing

Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
All India Institute of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00812669
What this trial is testing

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Who this might be right for
Leukemia
Cancer Trials Ireland 52
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Testing effectiveness (Phase 2)Study completedNCT00951457
What this trial is testing

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Arbeitsgemeinschaft medikamentoese Tumortherapie 20
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Next Page